pharmacy

Page 13 of 13« First...910111213

Moreover, there is no guarantee that being different does not to develop similar products or processes independently or design around patents owned or licensed by the Company, or that patents owned or licensed by the Company meaningful protection or competitive advantages.. This press release contains forward-looking statements based on management’s current expectations. These statements can be asked significantly from actual future events or results due to certain risks and uncertainties, including, without limitation, risks associated with drug development and manufacture, risks in extensive approval process by the United States Food and Drug Administration and the ,, delays in obtaining the necessary approvals for clinical testing, patient recruitment, Delays in the implementation of clinical trials, market acceptance of PI-88, PI-166 and other drugs, future capital needs, general economic conditions and other risks and uncertainties from in the to time in the Company’s filings with the Australian Securities Exchange and United States Securities and Exchange Commission.

About Progen:. Progen Pharmaceuticals is a globally focused biotechnology company focused on the discovery, development and commercialization of small molecule drugs primarily for the treatment of cancer Progen has operations in Australia and USA. Continue reading

Page 13 of 13« First...910111213